Biohaven Ltd.
BHVN
$8.20
-$0.17-2.03%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 110.31M | 111.98M | 104.33M | 95.95M | 89.24M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 708.37M | 792.58M | 801.36M | 751.53M | 713.21M |
| Operating Income | -708.37M | -792.58M | -801.36M | -751.53M | -713.21M |
| Income Before Tax | -737.38M | -778.97M | -766.11M | -887.82M | -845.69M |
| Income Tax Expenses | 1.44M | 1.14M | 859.00K | 775.00K | 735.00K |
| Earnings from Continuing Operations | -738.82 | -780.11 | -766.97 | -888.60 | -846.42 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -738.82M | -780.11M | -766.97M | -888.60M | -846.42M |
| EBIT | -708.37M | -792.58M | -801.36M | -751.53M | -713.21M |
| EBITDA | -698.45M | -782.77M | -792.68M | -742.88M | -705.36M |
| EPS Basic | -6.96 | -7.60 | -7.66 | -9.37 | -9.39 |
| Normalized Basic EPS | -4.24 | -4.85 | -4.91 | -4.76 | -4.79 |
| EPS Diluted | -6.96 | -7.60 | -7.66 | -9.37 | -9.39 |
| Normalized Diluted EPS | -4.24 | -4.85 | -4.91 | -4.76 | -4.79 |
| Average Basic Shares Outstanding | 430.32M | 411.19M | 399.74M | 385.14M | 364.80M |
| Average Diluted Shares Outstanding | 430.32M | 411.19M | 399.74M | 385.14M | 364.80M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |